Landewé, R., Heijde, D. v. d., Dougados, M., Baraliakos, X., Bosch, F. V. d., Gaffney, K., . . . Gensler, L. S. (2020). Induction of Sustained Clinical Remission in Early Axial Spondyloarthritis Following Certolizumab Pegol Treatment: 48-Week Outcomes from C-OPTIMISE. Adis, Springer Healthcare.
Chicago Style (17th ed.) CitationLandewé, Robert, et al. Induction of Sustained Clinical Remission in Early Axial Spondyloarthritis Following Certolizumab Pegol Treatment: 48-Week Outcomes from C-OPTIMISE. Adis, Springer Healthcare, 2020.
MLA (8th ed.) CitationLandewé, Robert, et al. Induction of Sustained Clinical Remission in Early Axial Spondyloarthritis Following Certolizumab Pegol Treatment: 48-Week Outcomes from C-OPTIMISE. Adis, Springer Healthcare, 2020.
Warning: These citations may not always be 100% accurate.